ESR1 and breast cancer: As we all know, BC, act as a heterogeneous disease, was divided into different clinical subtypes according to estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) (Dai et al., 2016).